Understanding Dengue IgM Antibody: Normal vs Optimal Ranges

?What is Dengue IgM Antibody?

Dengue IgM antibody is an immunoglobulin produced by the body in response to acute dengue virus infection. IgM antibodies typically appear within the first week of symptom onset and persist for 4–6 weeks, making them a key marker for detecting recent or active dengue infection. This test is commonly used in endemic regions to diagnose dengue fever during acute illness.

!Why It Matters

A positive Dengue IgM result may suggest recent dengue virus infection and helps distinguish acute infection from past exposure. Early detection is important for clinical management, reducing complications, and implementing appropriate public health measures in endemic areas. IgM positivity can also help differentiate dengue from other febrile illnesses presenting with similar symptoms.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• High fever lasting 3–7 days
• Severe headache and muscle/joint pain
• Rash appearing on the trunk or limbs
• Nausea, vomiting, and abdominal pain
• Bleeding manifestations (in severe cases)

How to Improve Your Levels

• 1Rest and fluid intake to support immune recovery during acute infection
• 2Acetaminophen or ibuprofen as recommended by your healthcare provider to manage fever and pain
• 3Avoid NSAIDs if possible due to bleeding risk in dengue; follow medical guidance
• 4Seek timely medical care to monitor for severe dengue (dengue hemorrhagic fever) and manage complications
• 5Use mosquito nets and repellents to prevent transmission to others and reinfection
• 6Follow local public health guidelines in endemic regions for isolation and monitoring

When to Test

Dengue IgM testing should be performed when dengue fever is clinically suspected, typically during the acute phase (within 3–7 days of symptom onset) in individuals presenting with fever, headache, and myalgia in dengue-endemic areas or recent travel to such regions.

Related Biomarkers